Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Asia
Pharma
Celltrion buy, Rexulti CRL, Glenmark-Hengrui—Fierce Pharma Asia
Celltrion bought a Lilly plant in the U.S. The FDA turned down Lundbeck and Otsuka's PTSD application. Hengrui and Glenmark signed an ADC deal.
Angus Liu
Sep 26, 2025 10:00am
Glenmark, Hengrui ink $1.1B deal for HER2 ADC
Sep 24, 2025 10:16am
BMS JV sale, biotech debuts, possible deals—Fierce Pharma Asia
Sep 19, 2025 8:36am
China deals, Daiichi-Merck ADC, Sun Pharma—Fierce Pharma Asia
Sep 11, 2025 8:50pm
Trump carves out generics from US-Japan trade deal
Sep 8, 2025 11:50am
Novartis-Argo, Eisai, Henlius—Fierce Pharma Asia
Sep 5, 2025 9:00am
